indomethacin has been researched along with Cholera Infantum in 99 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
Excerpt | Relevance | Reference |
---|---|---|
"A double-blind, double-dummy, crossover study was carried out in 8 centres to compare the efficacy and tolerability of 'controlled-release' ketoprofen tablets (200 mg) with that of indomethacin suppositories (100 mg) in out-patients with definite or classical rheumatoid arthritis." | 9.07 | A double-blind comparison of oral ketoprofen 'controlled release' and indomethacin suppository in the treatment of rheumatoid arthritis with special regard to morning stiffness and pain on awakening. ( Leden, I; Rubin, B; Uddenfeldt, P, 1993) |
"Despite a wide range of study designs, a multiplicity of international trials of diclofenac in osteoarthritis have disclosed similar results." | 9.06 | International experiences with diclofenac in osteoarthritis. ( Altman, R, 1986) |
"The effectiveness of fenclofenac in the treatment of rheumatoid arthritis was compared in a crossover double-blind study of 30 patients with that of indometacin over a period of two weeks." | 9.05 | [Fenclofenac in the treatment of rheumatoid arthritis (author's transl)]. ( Bachmann, F, 1980) |
"The efficacy of naproxen and indomethacin in the treatment of dysmenorrhea was compared in a double-blind, cross-over study." | 9.04 | Naproxen and indomethacin in the treatment of primary dysmenorrhea. ( Kajanoja, P; Vesanto, T, 1979) |
"A double-blind cross-over trial was carried out in 50 patients with definite rheumatoid arthritis, in order to compare the effects of 300 mg/day of ketoprofen with those of 600 mg/day of phenylbutazone, e." | 9.04 | A double-blind cross-over study of ketoprofen and phenylbutazone in rheumatoid arthritis. ( Peltola, P, 1976) |
"), in comparison with that of indomethacin was investigated in 30 patients with rheumatoid arthritis." | 9.04 | Clinical evaluation of ketoprofen (19.583 R.P.) in rheumatoid arthritis. Double-blind cross-over comparison with indomethacin. ( Fossgreen, J; Kirchheiner, B; Petersen, FO; Tophoj, E; Zachariae, E, 1976) |
"During a double-blind, randomized study on 30 patients affected with classic or definite rheumatoid arthritis, the efficacy and safety of treatment with diftalone in a per oral dosage of 500 mg/day were compared with those of indomethacin given orally at doses of 50-75 mg/day initially and 100 mg/day subsequently, for a treatment period of 24 months." | 9.04 | Comparative clinical trial with a new substance, Diftalone, versus indomethacin in 30 patients affected with rheumatoid arthritis. ( Bröll, H; Dunky, A; Eberl, R; Tausch, G, 1976) |
"To evaluate, for the first time, the efficacy of copper-indomethacin in the inhibition of aberrant crypt foci formation using the azoxymethane-induced adenocarcinoma model, to examine cell viability in the HCT-116 colorectal cancer cell line, gastrointestinal permeability, mitochondrial oxidative damage, and renal toxicity in rat models." | 7.76 | Inhibition of experimental colorectal cancer and reduction in renal and gastrointestinal toxicities by copper-indomethacin in rats. ( Bonin, AM; Davies, NM; Dillon, CT; Fukuda, C; Hambley, TW; Lay, PA; Teng, XW; Yáñez, JA, 2010) |
"A retrospective study to compare the incidence of NEC, NEC-related gastrointestinal complications and isolated gastrointestinal perforation among premature infants treated for a PDA with either, indomethacin alone (I), surgical ligation alone (L), or indomethacin followed by surgical ligation (I-L)." | 7.72 | Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus. ( Adams, JM; Adams, K; Baetiong, A; Chen, A; O'Donovan, DJ; Smith, EO; Weisman, LE, 2003) |
"A double-blind, double-dummy, crossover study was carried out in 8 centres to compare the efficacy and tolerability of 'controlled-release' ketoprofen tablets (200 mg) with that of indomethacin suppositories (100 mg) in out-patients with definite or classical rheumatoid arthritis." | 5.07 | A double-blind comparison of oral ketoprofen 'controlled release' and indomethacin suppository in the treatment of rheumatoid arthritis with special regard to morning stiffness and pain on awakening. ( Leden, I; Rubin, B; Uddenfeldt, P, 1993) |
"Despite a wide range of study designs, a multiplicity of international trials of diclofenac in osteoarthritis have disclosed similar results." | 5.06 | International experiences with diclofenac in osteoarthritis. ( Altman, R, 1986) |
"Data collected from more than 1,800 patients with rheumatoid arthritis or degenerative joint disease in Phase 3 clinical studies of isoxicam (Maxicam) indicated that the drug is well tolerated on both a short-term and a long-term basis." | 5.05 | Evaluation of the safety of isoxicam. ( Burch, FX, 1985) |
"The effectiveness of fenclofenac in the treatment of rheumatoid arthritis was compared in a crossover double-blind study of 30 patients with that of indometacin over a period of two weeks." | 5.05 | [Fenclofenac in the treatment of rheumatoid arthritis (author's transl)]. ( Bachmann, F, 1980) |
"The efficacy of naproxen and indomethacin in the treatment of dysmenorrhea was compared in a double-blind, cross-over study." | 5.04 | Naproxen and indomethacin in the treatment of primary dysmenorrhea. ( Kajanoja, P; Vesanto, T, 1979) |
"A double-blind cross-over trial was carried out in 50 patients with definite rheumatoid arthritis, in order to compare the effects of 300 mg/day of ketoprofen with those of 600 mg/day of phenylbutazone, e." | 5.04 | A double-blind cross-over study of ketoprofen and phenylbutazone in rheumatoid arthritis. ( Peltola, P, 1976) |
"Ketoprofen (100 mg/day) and indomethacin (100 mg/day) were compared in a double-blind cross-over trial of four weeks duration in 46 patients with rheumatoid arthritis." | 5.04 | Ketoprofen -- a new anti-rheumatic agent. ( Burry, HC; Grahame, R, 1976) |
"), in comparison with that of indomethacin was investigated in 30 patients with rheumatoid arthritis." | 5.04 | Clinical evaluation of ketoprofen (19.583 R.P.) in rheumatoid arthritis. Double-blind cross-over comparison with indomethacin. ( Fossgreen, J; Kirchheiner, B; Petersen, FO; Tophoj, E; Zachariae, E, 1976) |
"During a double-blind, randomized study on 30 patients affected with classic or definite rheumatoid arthritis, the efficacy and safety of treatment with diftalone in a per oral dosage of 500 mg/day were compared with those of indomethacin given orally at doses of 50-75 mg/day initially and 100 mg/day subsequently, for a treatment period of 24 months." | 5.04 | Comparative clinical trial with a new substance, Diftalone, versus indomethacin in 30 patients affected with rheumatoid arthritis. ( Bröll, H; Dunky, A; Eberl, R; Tausch, G, 1976) |
" lingzhi and its autodigested product (AD-GL) against gut inflammation and endogenous sepsis induced in mice by the oral administration of indomethacin (IND)." | 3.88 | Protection against Gut Inflammation and Sepsis in Mice by the Autodigested Product of the Lingzhi Medicinal Mushroom, Ganoderma lingzhi (Agaricomycetes). ( Adachi, Y; Igami, K; Ishibashi, KI; Ishimoto, Y; Ito, H; Miyazaki, T; Ohno, N; Yamanaka, D, 2018) |
"To evaluate, for the first time, the efficacy of copper-indomethacin in the inhibition of aberrant crypt foci formation using the azoxymethane-induced adenocarcinoma model, to examine cell viability in the HCT-116 colorectal cancer cell line, gastrointestinal permeability, mitochondrial oxidative damage, and renal toxicity in rat models." | 3.76 | Inhibition of experimental colorectal cancer and reduction in renal and gastrointestinal toxicities by copper-indomethacin in rats. ( Bonin, AM; Davies, NM; Dillon, CT; Fukuda, C; Hambley, TW; Lay, PA; Teng, XW; Yáñez, JA, 2010) |
"A retrospective study to compare the incidence of NEC, NEC-related gastrointestinal complications and isolated gastrointestinal perforation among premature infants treated for a PDA with either, indomethacin alone (I), surgical ligation alone (L), or indomethacin followed by surgical ligation (I-L)." | 3.72 | Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus. ( Adams, JM; Adams, K; Baetiong, A; Chen, A; O'Donovan, DJ; Smith, EO; Weisman, LE, 2003) |
"Indomethacin, a nonsteroidal anti-inflammatory drug, induces the formation of gastrointestinal ulceration both in experimental animals and in humans." | 3.68 | Structural and morphometric analysis of murine small intestine after indomethacin administration. ( Carr, KE; Ettarh, RR, 1993) |
"Ankylosing spondylitis is a systemic rheumatic disorder characterized by inflammation of the spine, sacroiliac, and large peripheral joints." | 2.66 | Efficacy of diclofenac in ankylosing spondylitis. ( Calabro, JJ, 1986) |
"Upper gastrointestinal haemorrhage and pseudomembranous colitis are potentially fatal manifestations of drug therapy." | 2.36 | Drug-induced gastrointestinal disease. ( Bramble, MG; Record, CO, 1978) |
"Treatment with uric acid protected Caco-2 cells from indomethacin-induced oxidative stress, lipid peroxidation, and cytotoxicity." | 1.46 | Uric acid ameliorates indomethacin-induced enteropathy in mice through its antioxidant activity. ( Furuhashi, H; Higashiyama, M; Hokari, R; Komoto, S; Kurihara, C; Maruta, K; Matsuo, H; Miura, S; Nagao, S; Narimatsu, K; Okada, Y; Sato, H; Shirakabe, K; Takajo, T; Tomita, K; Watanabe, C; Yasutake, Y; Yoshikawa, K, 2017) |
"Quercetin was the most efficient in protecting against mitochondrial dysfunction; this could be due to its ability to enter cells and accumulate in mitochondria." | 1.38 | Differential protective effects of quercetin, resveratrol, rutin and epigallocatechin gallate against mitochondrial dysfunction induced by indomethacin in Caco-2 cells. ( Carrasco-Pozo, C; Gotteland, M; Mizgier, ML; Speisky, H, 2012) |
"Indomethacin (25mg/kg) was administered orally by a single application to rat (Wistar Han II, 200-250g)." | 1.35 | Type and distribution of indomethacin-induced lesions in the gastrointestinal tract of rat. ( Bures, J; Kunes, M; Kvetina, J, 2009) |
" This molecular modification may offer a general route to safer antiinflammatory agents, potentially suitable for chronic use in conditions such as neurodegenerative disorders." | 1.32 | Synthesis and pharmacological evaluation of amide conjugates of NSAIDs with L-cysteine ethyl ester, combining potent antiinflammatory and antioxidant properties with significantly reduced gastrointestinal toxicity. ( Charitos, C; Doulgkeris, C; Galanakis, D; Gavalas, A; Kourounakis, AP; Kourounakis, PN; Kravaritou, C; Rekka, EA; Tsiakitzis, KC, 2004) |
"This prospective study evaluated heterotopic ossification prophylaxis with indomethacin for 14 days in 201 consecutive patients undergoing total hip arthroplasty." | 1.30 | General short-term indomethacin prophylaxis to prevent heterotopic ossification in total hip arthroplasty. ( Frank, E; Hofmann, S; Metzenroth, H; Ritschl, P; Salzer, M; Trnka, HJ, 1999) |
"CDH can be due to transformed migraine (TM), new daily persistent headache (NDPH), chronic tension-type headache, and HC." | 1.29 | Hemicrania continua and symptomatic medication overuse. ( Silberstein, SD; Young, WB, 1993) |
" The plasma levels of IM after the oral administration of IM-OE and IM-BE were comparatively low compared with those after IM, with a small bioavailability (2." | 1.29 | Pharmacokinetics of indomethacin ester prodrugs: gastrointestinal and hepatic toxicity and the hydrolytic capacity of various tissues in rats. ( Iwaki, M; Muraoka, O; Nagai, T; Ogiso, T; Tanabe, G; Tanino, T; Ueda, Y, 1996) |
" All marmosets given 12 mg/kg/day and one marmoset given 6 mg/kg/day died during the dosing period (within 20 days)." | 1.28 | Evaluation of the toxicity of indomethacin in a 4-week study, by oral route, in the marmoset (Callithrix jacchus). ( Conz, A; Galli, CL; Giachetti, C; Oberto, G, 1990) |
" A preliminary bioavailability study of two of the lead structures is presented." | 1.27 | Antiinflammatory activity of substituted 6-hydroxypyrimido[2,1-f]purine-2,4,8(1H,3H,9H)-triones. Atypical nonsteroidal antiinflammatory agents. ( Blythin, DJ; Bober, LA; Chiu, PJ; Conn, DJ; Domalski, MS; Kaminski, JJ; Solomon, DM; Spitler, J; Verbiar, LL; Wong, SC, 1986) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 57 (57.58) | 18.7374 |
1990's | 15 (15.15) | 18.2507 |
2000's | 17 (17.17) | 29.6817 |
2010's | 10 (10.10) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Walsh, DA | 1 |
Moran, HW | 1 |
Shamblee, DA | 1 |
Welstead, WJ | 1 |
Nolan, JC | 1 |
Sancilio, LF | 1 |
Graff, G | 1 |
Blythin, DJ | 1 |
Kaminski, JJ | 1 |
Domalski, MS | 1 |
Spitler, J | 1 |
Solomon, DM | 1 |
Conn, DJ | 1 |
Wong, SC | 1 |
Verbiar, LL | 1 |
Bober, LA | 1 |
Chiu, PJ | 1 |
Khanna, IK | 1 |
Weier, RM | 1 |
Yu, Y | 1 |
Xu, XD | 1 |
Koszyk, FJ | 1 |
Collins, PW | 1 |
Koboldt, CM | 1 |
Veenhuizen, AW | 1 |
Perkins, WE | 1 |
Casler, JJ | 1 |
Masferrer, JL | 1 |
Zhang, YY | 1 |
Gregory, SA | 1 |
Seibert, K | 1 |
Isakson, PC | 1 |
Kalgutkar, AS | 1 |
Crews, BC | 1 |
Rowlinson, SW | 1 |
Marnett, AB | 1 |
Kozak, KR | 1 |
Remmel, RP | 1 |
Marnett, LJ | 1 |
Galanakis, D | 1 |
Kourounakis, AP | 1 |
Tsiakitzis, KC | 1 |
Doulgkeris, C | 1 |
Rekka, EA | 1 |
Gavalas, A | 1 |
Kravaritou, C | 1 |
Charitos, C | 1 |
Kourounakis, PN | 1 |
Sharma, M | 1 |
Ray, SM | 1 |
Chamoun-Emanuelli, AM | 1 |
Bryan, LK | 1 |
Cohen, ND | 1 |
Tetrault, TL | 1 |
Szule, JA | 1 |
Barhoumi, R | 1 |
Whitfield-Cargile, CM | 1 |
Martini, S | 1 |
Aceti, A | 1 |
Galletti, S | 1 |
Beghetti, I | 1 |
Faldella, G | 1 |
Corvaglia, L | 1 |
Ishimoto, Y | 1 |
Ishibashi, KI | 1 |
Yamanaka, D | 1 |
Adachi, Y | 1 |
Ito, H | 1 |
Igami, K | 1 |
Miyazaki, T | 1 |
Ohno, N | 1 |
Yasutake, Y | 1 |
Tomita, K | 1 |
Higashiyama, M | 1 |
Furuhashi, H | 1 |
Shirakabe, K | 1 |
Takajo, T | 1 |
Maruta, K | 1 |
Sato, H | 1 |
Narimatsu, K | 1 |
Yoshikawa, K | 1 |
Okada, Y | 1 |
Kurihara, C | 1 |
Watanabe, C | 1 |
Komoto, S | 1 |
Nagao, S | 1 |
Matsuo, H | 1 |
Miura, S | 1 |
Hokari, R | 1 |
Fawole, OA | 1 |
Ndhlala, AR | 1 |
Amoo, SO | 1 |
Finnie, JF | 1 |
Van Staden, J | 1 |
Kunes, M | 2 |
Kvetina, J | 2 |
Bures, J | 2 |
Bonin, AM | 1 |
Yáñez, JA | 1 |
Fukuda, C | 1 |
Teng, XW | 1 |
Dillon, CT | 1 |
Hambley, TW | 1 |
Lay, PA | 1 |
Davies, NM | 1 |
Bhandari, SV | 1 |
Parikh, JK | 1 |
Bothara, KG | 1 |
Chitre, TS | 1 |
Lokwani, DK | 1 |
Devale, TL | 1 |
Modhave, NS | 1 |
Pawar, VS | 1 |
Panda, S | 1 |
Fujino, H | 1 |
Murayama, T | 1 |
Carrasco-Pozo, C | 2 |
Speisky, H | 2 |
Brunser, O | 1 |
Pastene, E | 1 |
Gotteland, M | 2 |
Kholova, D | 1 |
Tlaskalova-Hogenova, H | 1 |
Pavlik, M | 1 |
Mizgier, ML | 1 |
O'Donovan, DJ | 1 |
Baetiong, A | 1 |
Adams, K | 1 |
Chen, A | 1 |
Smith, EO | 1 |
Adams, JM | 1 |
Weisman, LE | 1 |
Rainsford, KD | 1 |
Stetsko, PI | 1 |
Sirko, SP | 1 |
Debski, S | 1 |
BUCHMANN, E | 1 |
Troost, FJ | 1 |
Saris, WH | 1 |
Brummer, RJ | 1 |
Petruzzelli, M | 1 |
Moschetta, A | 1 |
Renooij, W | 1 |
de Smet, MB | 1 |
Palasciano, G | 1 |
Portincasa, P | 1 |
van Erpecum, KJ | 1 |
Dalby, AB | 1 |
Frank, DN | 1 |
St Amand, AL | 1 |
Bendele, AM | 1 |
Pace, NR | 1 |
Laudanno, O | 1 |
Vasconcelos, L | 1 |
Catalana, J | 1 |
Cesolari, J | 1 |
Kirkova, M | 1 |
Kesiova, M | 1 |
Konstantinova, S | 1 |
Alexandrova, A | 1 |
Petrov, L | 1 |
Tsvetanova, E | 1 |
Todorov, S | 1 |
Dial, EJ | 1 |
Darling, RL | 1 |
Lichtenberger, LM | 1 |
Onose, J | 1 |
Imai, T | 1 |
Hasumura, M | 1 |
Ueda, M | 1 |
Ozeki, Y | 1 |
Hirose, M | 1 |
Lehtinen, K | 2 |
Kaarela, K | 2 |
Mäkisara, P | 1 |
Holttinen, K | 1 |
Gordin, A | 2 |
Mizushima, Y | 1 |
Guobis, G | 1 |
Iushenaite, Ia | 1 |
Tabata, K | 2 |
Okabe, S | 2 |
Schiantarelli, P | 1 |
Cadel, S | 1 |
Kawai, K | 1 |
Tamura, S | 1 |
Morimoto, S | 1 |
Ishii, H | 1 |
Kuzuna, S | 1 |
Felder, M | 1 |
Bachmann, F | 1 |
Cunnane, SC | 1 |
Huston, GJ | 1 |
Beale, JP | 1 |
Thillainayagam, AV | 1 |
Tabaqchali, S | 1 |
Warrington, SJ | 1 |
Farthing, MJ | 1 |
Uddenfeldt, P | 1 |
Leden, I | 1 |
Rubin, B | 1 |
Ettarh, RR | 1 |
Carr, KE | 1 |
Young, WB | 1 |
Silberstein, SD | 1 |
Turek, JJ | 1 |
Schoenlein, IA | 1 |
Ogiso, T | 1 |
Iwaki, M | 1 |
Tanino, T | 1 |
Nagai, T | 1 |
Ueda, Y | 1 |
Muraoka, O | 1 |
Tanabe, G | 1 |
Balint, GA | 1 |
Meddings, JB | 1 |
Gibbons, I | 1 |
Hofmann, S | 1 |
Trnka, HJ | 1 |
Metzenroth, H | 1 |
Frank, E | 1 |
Ritschl, P | 1 |
Salzer, M | 1 |
Playford, RJ | 1 |
Floyd, DN | 1 |
Macdonald, CE | 1 |
Calnan, DP | 1 |
Adenekan, RO | 1 |
Johnson, W | 1 |
Goodlad, RA | 1 |
Marchbank, T | 1 |
Beck, PL | 1 |
Xavier, R | 1 |
Lu, N | 1 |
Nanda, NN | 1 |
Dinauer, M | 1 |
Podolsky, DK | 1 |
Seed, B | 1 |
Yamagiwa, S | 1 |
Yoshida, Y | 1 |
Halder, RC | 1 |
Weerasinghe, A | 1 |
Sugahara, S | 1 |
Asakura, H | 1 |
Abo, T | 1 |
Ojala, R | 1 |
Ruuska, T | 1 |
Karikoski, R | 1 |
Ikonen, RS | 1 |
Tammela, O | 1 |
Buisseret, PD | 1 |
Youlten, LF | 1 |
Heinzelmann, DI | 1 |
Lessof, MH | 1 |
Bramble, MG | 1 |
Record, CO | 1 |
Mirelli, E | 2 |
Fichera, G | 2 |
Volpe, AD | 1 |
Lasala, M | 1 |
Valtonen, EJ | 1 |
Busson, M | 1 |
Ammitzbøll, F | 1 |
Kajanoja, P | 1 |
Vesanto, T | 1 |
Rosenbaum, ES | 1 |
Barbieri, EJ | 1 |
Ciccolunghi, SN | 1 |
Schubiger, BI | 1 |
Reddrop, R | 1 |
Peltola, P | 1 |
Grahame, R | 1 |
Burry, HC | 1 |
Zutshi, D | 1 |
Mason, M | 1 |
Fossgreen, J | 1 |
Kirchheiner, B | 1 |
Petersen, FO | 1 |
Tophoj, E | 1 |
Zachariae, E | 1 |
Tausch, G | 2 |
Bröll, H | 2 |
Dunky, A | 1 |
Eberl, R | 2 |
Shriver, DA | 1 |
Dove, PA | 1 |
White, CB | 1 |
Sandor, A | 1 |
Rosenthale, ME | 1 |
Swift, GL | 1 |
Arnold, J | 1 |
Williams, GT | 1 |
Williams, BD | 1 |
Rhodes, J | 1 |
Khan, F | 1 |
Jones, RD | 1 |
Baynes, RE | 1 |
Nimitz, CT | 1 |
Oberto, G | 1 |
Conz, A | 1 |
Giachetti, C | 1 |
Galli, CL | 1 |
Schlegel, SI | 1 |
Paulus, HE | 1 |
Inman, WH | 1 |
Heere, LP | 1 |
Ahonen, M | 1 |
Forsberg, S | 1 |
Luukkainen, R | 1 |
Martio, J | 1 |
Mutru, O | 1 |
Nykänen, E | 1 |
Nykänen, P | 1 |
Pesonen, J | 1 |
Altman, R | 1 |
Calabro, JJ | 1 |
Sotka, S | 1 |
Nuutila, J | 1 |
Burch, FX | 1 |
Aguwa, CN | 1 |
Marcolongo, R | 1 |
Kinsella, TD | 1 |
MacKenzie, KR | 1 |
Kim, SO | 1 |
Johnson, LG | 1 |
Caruso, I | 1 |
Rooney, PJ | 1 |
Watkins, C | 1 |
Ahola, SJ | 1 |
Gray, GI | 1 |
Dick, WC | 1 |
Andersson, S | 1 |
Sun, DC | 1 |
Cuthbert, MF | 1 |
Klein, G | 1 |
Fellner, S | 1 |
Fellner, R | 1 |
Sturrock, RD | 1 |
Hart, FD | 1 |
Rubin, A | 1 |
Chernish, SM | 1 |
Crabtree, R | 1 |
Gruber, CM | 1 |
Helleberg, L | 1 |
Rodda, BE | 1 |
Warrick, P | 1 |
Wolen, RL | 1 |
Ridolfo, AS | 1 |
Sochor, H | 1 |
Bontoux, D | 1 |
Green, AY | 1 |
Green, D | 1 |
Rothermich, NO | 2 |
Baumann, JC | 1 |
Hoffmann, U | 1 |
Henrard, JC | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Effect of Resistant Starch Consumption on Zinc Hemostasis in Malawian Children at Risk for Zinc Deficiency[NCT01811836] | 20 participants (Actual) | Interventional | 2013-03-31 | Completed | |||
GpCRC Pediatric Gastroparesis Registry 2: Characterization and Clinical Course of Symptoms and Gastric Emptying in Pediatric, Adolescent, and Young Adult Participants With Symptoms of Gastroparesis[NCT05981300] | 216 participants (Anticipated) | Observational [Patient Registry] | 2024-02-28 | Not yet recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
5 reviews available for indomethacin and Cholera Infantum
Article | Year |
---|---|
To Feed or Not to Feed: A Critical Overview of Enteral Feeding Management and Gastrointestinal Complications in Preterm Neonates with a Patent Ductus Arteriosus.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Ductus Arteriosus | 2019 |
[Novel anti-cancer effects of indomethacin: exploring the cyclooxygenase-inhibition-independent effects].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Arachidonic Acid; CD36 Anti | 2011 |
[Pharmacodynamics and adverse effects of modern nonsteroid anti-inflammatory agents].
Topics: Adult; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Clinical Trials as Topic; Diclofena | 1981 |
Drug-induced gastrointestinal disease.
Topics: Adrenal Cortex Hormones; Cathartics; Colon; Constipation; Diarrhea; Enterocolitis, Pseudomembranous; | 1978 |
Non-steroidal and analgesic therapy in the elderly.
Topics: Acetaminophen; Aged; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents; Apazone; Aspirin; Cen | 1986 |
30 trials available for indomethacin and Cholera Infantum
Article | Year |
---|---|
Recombinant human lactoferrin ingestion attenuates indomethacin-induced enteropathy in vivo in healthy volunteers.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Double-Bli | 2003 |
Tolerability and efficacy of a slow-release indomethacin tablet in ankylosing spondylitis.
Topics: Adult; Capsules; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Drug To | 1984 |
Pro-drugs of non-steroidal anti-inflammatory agents.
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Double-Blind Method; Gast | 1983 |
[Pharmacodynamics and adverse effects of modern nonsteroid anti-inflammatory agents].
Topics: Adult; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Clinical Trials as Topic; Diclofena | 1981 |
[Fenclofenac in the treatment of rheumatoid arthritis (author's transl)].
Topics: Arthritis, Rheumatoid; Clinical Trials as Topic; Double-Blind Method; Female; Gastrointestinal Disea | 1980 |
Interrelationships between Helicobacter pylori infection, nonsteroidal antiinflammatory drugs and gastroduodenal disease. A prospective study in healthy volunteers.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; beta-Cyclodextrins; Cyclodextrins; Double-Blind Meth | 1994 |
A double-blind comparison of oral ketoprofen 'controlled release' and indomethacin suppository in the treatment of rheumatoid arthritis with special regard to morning stiffness and pain on awakening.
Topics: Administration, Rectal; Adult; Aged; Ambulatory Care; Arthritis, Rheumatoid; Central Nervous System | 1993 |
Prostaglandin-synthesis inhibitors in prophylaxis of food intolerance.
Topics: Acute Disease; Adult; Animals; Aspirin; Bivalvia; Chickens; Clinical Trials as Topic; Dairy Products | 1978 |
Endoscopic study of the gastro-intestinal tolerance of glucamethacin.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; | 1978 |
A comparative study on ibuprofen (Brufen) and indomethacin in non-articular rheumatism.
Topics: Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Gastrointestinal Diseases; H | 1978 |
Fenbufen and indomethacin in the treatment of rheumatoid arthritis. A comparative double-blind, crossover study.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Biphenyl Compounds; Cli | 1979 |
Naproxen and indomethacin in the treatment of primary dysmenorrhea.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Dysmenorrhea; Female; Gastroi | 1979 |
A double-blind cross-over study of ketoprofen and phenylbutazone in rheumatoid arthritis.
Topics: Analgesics; Arthritis, Rheumatoid; Benzophenones; Clinical Trials as Topic; Drug Evaluation; Gastroi | 1976 |
Ketoprofen -- a new anti-rheumatic agent.
Topics: Analgesics; Arthritis, Rheumatoid; Benzophenones; Clinical Trials as Topic; Drug Evaluation; Gastroi | 1976 |
Ketoprofen in rheumatoid arthritis: its tolerance and therapeutic effect.
Topics: Adult; Aged; Analgesics; Arthritis, Rheumatoid; Benzophenones; Clinical Trials as Topic; Drug Evalua | 1976 |
Clinical evaluation of ketoprofen (19.583 R.P.) in rheumatoid arthritis. Double-blind cross-over comparison with indomethacin.
Topics: Adult; Aged; Analgesics; Arthritis, Rheumatoid; Benzophenones; Clinical Trials as Topic; Drug Evalua | 1976 |
Comparative clinical trial with a new substance, Diftalone, versus indomethacin in 30 patients affected with rheumatoid arthritis.
Topics: Administration, Oral; Arthritis, Rheumatoid; Clinical Trials as Topic; Drug Evaluation; Female; Gast | 1976 |
A comparison of upper gastrointestinal mucosal damage by standard and delayed-release indomethacin.
Topics: Adult; Aged; Aged, 80 and over; Delayed-Action Preparations; Double-Blind Method; Duodenal Ulcer; Du | 1992 |
Piroxicam in acute musculoskeletal disorders and sport injuries.
Topics: Acute Disease; Adult; Athletic Injuries; Central Nervous System Diseases; Clinical Trials as Topic; | 1987 |
A six-month follow-up study of a slow-release indomethacin tablet in rheumatic diseases.
Topics: Adult; Aged; Aged, 80 and over; Central Nervous System Diseases; Clinical Trials as Topic; Delayed-A | 1987 |
International experiences with diclofenac in osteoarthritis.
Topics: Aspirin; Clinical Trials as Topic; Diclofenac; Diflunisal; Double-Blind Method; Gastrointestinal Dis | 1986 |
Efficacy of diclofenac in ankylosing spondylitis.
Topics: Adult; Aged; Clinical Trials as Topic; Diclofenac; Double-Blind Method; Female; Gastrointestinal Dis | 1986 |
Comparison of a slow-release indomethacin tablet and naproxen in osteoarthrosis.
Topics: Adult; Aged; Central Nervous System Diseases; Clinical Trials as Topic; Delayed-Action Preparations; | 1985 |
Evaluation of the safety of isoxicam.
Topics: Aged; Arthritis, Rheumatoid; Aspirin; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation | 1985 |
Evaluation of indomethacin by a controlled, cross-over technique in 30 patients with ankylosing spondylitis.
Topics: Alkaline Phosphatase; Anemia, Hypochromic; Aspartate Aminotransferases; Aspirin; Central Nervous Sys | 1967 |
A short-term double-blind controlled trial of prenazone (DA 2370) in rheumatoid arthritis.
Topics: Acetaminophen; Administration, Oral; Adolescent; Adult; Aged; Alkenes; Analgesics; Anti-Inflammatory | 1974 |
[Indomethacin in rheumatic diseases with special reference to ophthalmologic studies].
Topics: Allopurinol; Arthritis, Rheumatoid; Azathioprine; Blood Cells; Capsules; Clinical Trials as Topic; E | 1972 |
Double-blind cross-over comparison of indomethacin, flurbiprofen, and placebo in ankylosing spondylitis.
Topics: Acetaminophen; Adult; Anti-Inflammatory Agents; Biphenyl Compounds; Blood Sedimentation; Clinical Tr | 1974 |
A profile of the physiological disposition and gastro-intestinal effects of fenoprofen in man.
Topics: Administration, Oral; Adult; Age Factors; Animals; Anti-Inflammatory Agents; Aspirin; Biotransformat | 1974 |
[Gastric protection with sulfated polysaccharides. Study during anti-inflammatory treatment].
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Clinical Trials as Topic; Drug Antagonism; Drug T | 1971 |
65 other studies available for indomethacin and Cholera Infantum
Article | Year |
---|---|
Antiinflammatory agents. 4. Syntheses and biological evaluation of potential prodrugs of 2-amino-3-benzoylbenzeneacetic acid and 2-amino-3-(4-chlorobenzoyl)benzeneacetic acid.
Topics: Acetamides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Benzeneacetam | 1990 |
Antiinflammatory activity of substituted 6-hydroxypyrimido[2,1-f]purine-2,4,8(1H,3H,9H)-triones. Atypical nonsteroidal antiinflammatory agents.
Topics: Animals; Anti-Inflammatory Agents; Arthritis; Biological Availability; Cyclooxygenase Inhibitors; Ga | 1986 |
1,2-Diarylimidazoles as potent, cyclooxygenase-2 selective, and orally active antiinflammatory agents.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Carrageenan; Cyclooxygena | 1997 |
Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Amides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line | 2000 |
Synthesis and pharmacological evaluation of amide conjugates of NSAIDs with L-cysteine ethyl ester, combining potent antiinflammatory and antioxidant properties with significantly reduced gastrointestinal toxicity.
Topics: Amides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cholesterol; Cysteine; Drug | 2004 |
Synthesis and biological evaluation of amide derivatives of (5,6-dimethoxy-2,3-dihydro-1H-inden-1-yl)acetic acid as anti-inflammatory agents with reduced gastrointestinal ulcerogenecity.
Topics: Acetates; Amides; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthri | 2008 |
NSAIDs disrupt intestinal homeostasis by suppressing macroautophagy in intestinal epithelial cells.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Epithelial Cells; Gastrointestinal Diseases; Goble | 2019 |
Protection against Gut Inflammation and Sepsis in Mice by the Autodigested Product of the Lingzhi Medicinal Mushroom, Ganoderma lingzhi (Agaricomycetes).
Topics: Animals; beta-Glucans; Cells, Cultured; Cytokines; Fungal Polysaccharides; Gastrointestinal Diseases | 2018 |
Uric acid ameliorates indomethacin-induced enteropathy in mice through its antioxidant activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Caco-2 Cells; Disease Models | 2017 |
Anti-inflammatory and phytochemical properties of twelve medicinal plants used for treating gastro-intestinal ailments in South Africa.
Topics: Alkaloids; Anti-Inflammatory Agents; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; | 2009 |
Type and distribution of indomethacin-induced lesions in the gastrointestinal tract of rat.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Gastrointestinal Diseases; I | 2009 |
Inhibition of experimental colorectal cancer and reduction in renal and gastrointestinal toxicities by copper-indomethacin in rats.
Topics: Acetylglucosaminidase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Azoxymethane; Carcinogens; | 2010 |
Design, synthesis, and evaluation of anti-inflammatory, analgesic, ulcerogenicity, and nitric oxide releasing studies of novel indomethacin analogs as non-ulcerogenic derivatives.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Drug Design; Gastrointestinal Diseases | 2010 |
Apple peel polyphenols protect against gastrointestinal mucosa alterations induced by indomethacin in rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Chlorogenic Acid; Disease Models, Animal; Flavonoid | 2011 |
Absorption kinetics of 5-aminosalicylic acid in rat: influence of indomethacin-induced gastrointestinal lesions and Escherichia Coli Nissle 1917 medication.
Topics: Absorption; Animals; Anti-Inflammatory Agents, Non-Steroidal; Escherichia coli; Gastrointestinal Dis | 2011 |
Differential protective effects of quercetin, resveratrol, rutin and epigallocatechin gallate against mitochondrial dysfunction induced by indomethacin in Caco-2 cells.
Topics: Adenosine Triphosphate; Caco-2 Cells; Catechin; Drug Interactions; Electron Transport Complex I; Gas | 2012 |
Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus.
Topics: Birth Weight; Cardiac Surgical Procedures; Cardiovascular Agents; Ductus Arteriosus, Patent; Enteroc | 2003 |
Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; D | 2003 |
THE ANTIRHEUMATIC EFFECT OF INDOMETHACIN.
Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Antirheumatic Agents; Arthritis; Arthritis, Rheu | 1965 |
Indomethacin enhances bile salt detergent activity: relevance for NSAIDs-induced gastrointestinal mucosal injury.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bile Acids and Salts; Biological Transport; Diseas | 2006 |
Culture-independent analysis of indomethacin-induced alterations in the rat gastrointestinal microbiota.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Ecosystem; Enterococcus faecalis; Female; Gastroin | 2006 |
Anti-inflammatory effect of bioflora probiotic administered orally or subcutaneously with live or dead bacteria.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Bi | 2006 |
In vivo effects of amtolmetin guacyl on lipid peroxidation and antioxidant defence systems in different models of gastrointestinal injury.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Disease Models, Animal; Ethanol; Gas | 2007 |
Importance of biliary excretion of indomethacin in gastrointestinal and hepatic injury.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biliary Tract; Chemical and Drug Induced Liver Inj | 2008 |
Evaluation of subchronic toxicity of dietary administered Cry1Ab protein from Bacillus thuringiensis var. Kurustaki HD-1 in F344 male rats with chemically induced gastrointestinal impairment.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bacillus thuringiensis; Bacillu | 2008 |
Effects of 16,16-dimethyl-PGE2-methyl ester on aspirin- and indomethacin-induced gastric and intestinal lesions in mini pigs.
Topics: 16,16-Dimethylprostaglandin E2; Animals; Aspirin; Female; Gastrointestinal Diseases; Indomethacin; I | 1983 |
Piroxicam pharmacologic activity and gastrointestinal damage by oral and rectal route. Comparison with oral indometacin and phenylbutazone.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Migration Inhibition; E | 1981 |
Pharmacology of 4-benzyol-1-indancarboxylic acid (TAI-901) and 4-(4-methylbenzoyl)-1-indancarboxylic acid (TAI-908).
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dogs; Female; Gastrointestinal Disease | 1982 |
[Non-steroidal antirheumatics: side-effects and interactions].
Topics: Anemia, Aplastic; Anti-Inflammatory Agents, Non-Steroidal; Coumarins; Drug Interactions; Gastrointes | 1982 |
Maternal essential fatty acid supplementation increases zinc absorption in neonatal rats: relevance to the defect in zinc absorption in acrodermatitis enteropathica.
Topics: Acrodermatitis; Animals; Arachidonic Acids; Fatty Acids, Essential; Female; Gastrointestinal Disease | 1982 |
Local buccal mucosal effects of aspirin, indomethacin and isoxepac: their relationship to gastrointestinal damage.
Topics: Acetates; Anti-Inflammatory Agents; Aspirin; Cheek; Dibenzoxepins; Gastrointestinal Diseases; Humans | 1981 |
Indomethacin and CME.
Topics: Aged; Cataract Extraction; Edema; Female; Gastrointestinal Diseases; Humans; Indomethacin; Macula Lu | 1980 |
Structural and morphometric analysis of murine small intestine after indomethacin administration.
Topics: Animals; Duodenum; Gastrointestinal Diseases; Ileum; Indomethacin; Intestine, Small; Jejunum; Male; | 1993 |
Hemicrania continua and symptomatic medication overuse.
Topics: Adult; Ergotamine; Female; Gastrointestinal Diseases; Humans; Indomethacin; Middle Aged; Migraine Di | 1993 |
Indomethacin-induced gastrointestinal ulcers in rats: effects of dietary fatty acids and endotoxin.
Topics: Animals; Corn Oil; Dietary Fats, Unsaturated; Endotoxins; Fatty Acids; Gastrointestinal Diseases; In | 1993 |
Pharmacokinetics of indomethacin ester prodrugs: gastrointestinal and hepatic toxicity and the hydrolytic capacity of various tissues in rats.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Li | 1996 |
A novel approach to reduce the unwanted gastric side-effects of orally administered non-steroidal anti-inflammatory drugs in rats.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cysteine; Drug Therapy, Comb | 1997 |
Discrimination of site-specific alterations in gastrointestinal permeability in the rat.
Topics: Animals; Aspirin; Biological Transport; Cyclooxygenase Inhibitors; Digestive System; Disease Models, | 1998 |
Discrimination of site-specific alterations in gastrointestinal permeability in the rat.
Topics: Animals; Aspirin; Biological Transport; Cyclooxygenase Inhibitors; Digestive System; Disease Models, | 1998 |
Discrimination of site-specific alterations in gastrointestinal permeability in the rat.
Topics: Animals; Aspirin; Biological Transport; Cyclooxygenase Inhibitors; Digestive System; Disease Models, | 1998 |
Discrimination of site-specific alterations in gastrointestinal permeability in the rat.
Topics: Animals; Aspirin; Biological Transport; Cyclooxygenase Inhibitors; Digestive System; Disease Models, | 1998 |
General short-term indomethacin prophylaxis to prevent heterotopic ossification in total hip arthroplasty.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthropl | 1999 |
Bovine colostrum is a health food supplement which prevents NSAID induced gut damage.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Cell Culture Techniques; Cell Division; Ce | 1999 |
Mechanisms of NSAID-induced gastrointestinal injury defined using mutant mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; DNA-Binding Proteins; Enteritis; Fucosy | 2000 |
Mechanisms involved in enteropathy induced by administration of nonsteroidal antiinflammatory drugs (NSAIDS).
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Appendix; Colon; Fluorescent Antibody Technique; G | 2001 |
Gastroesophageal endoscopic findings and gastrointestinal symptoms in preterm neonates with and without perinatal indomethacin exposure.
Topics: Biopsy; Case-Control Studies; Ductus Arteriosus, Patent; Endoscopy, Gastrointestinal; Enteral Nutrit | 2001 |
Inhibition by aspirin of gastrointestinal toxicity induced by indomethacin in polyarthritic rats.
Topics: Animals; Arthritis; Arthritis, Experimental; Aspirin; Disease Models, Animal; Dose-Response Relation | 1979 |
Comparisons of tolerability findings in international clinical trials.
Topics: Arthritis, Rheumatoid; Aspirin; Cardiovascular System; Clinical Trials as Topic; Diclofenac; Drug To | 1979 |
[Gastrointestinal diseases caused by drugs, especially by anti-inflammatory agents].
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Betamethasone; Dogs; Gastrointestinal Diseases; Indometh | 1978 |
A profile of the gastrointestinal toxicity of aspirin, indomethacin, oxaprozin, phenylbutazone, and fentiazac in arthritic and Lewis normal rats.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Arthritis; Arthritis, Experimental; Aspirin; Body Weigh | 1977 |
Nonsteroidal anti-inflammatory drug toxicosis in dogs and cats: 240 cases (1989-1990)
Topics: Accidents; Acetaminophen; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cat Diseases; C | 1992 |
Evaluation of the toxicity of indomethacin in a 4-week study, by oral route, in the marmoset (Callithrix jacchus).
Topics: Administration, Oral; Animals; Blood Cell Count; Blood Chemical Analysis; Body Weight; Callithrix; F | 1990 |
Non-steroidal anti-inflammatory drugs: assessment of risks.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Central Nervous Syste | 1987 |
Gastrointestinal effects of the extracts of Rhigiocarya racemifera (Menispermaceae).
Topics: Animals; Cimetidine; Female; Gastrointestinal Diseases; Glycosides; Indomethacin; Ligation; Male; Mi | 1985 |
[Undesired collateral effects of indomethacin].
Topics: Arthritis, Rheumatoid; Gastrointestinal Diseases; Headache; Histamine Release; Humans; Indomethacin | 1972 |
[Undesired collateral effects of antirheumatic drugs: indomethacin].
Topics: Arthritis, Rheumatoid; Drug Eruptions; Gastrointestinal Diseases; Headache; Humans; Indomethacin; Pa | 1972 |
[Side effects of drugs. 2. Gastrointestinal side effects].
Topics: Adrenocorticotropic Hormone; Caffeine; Drug-Related Side Effects and Adverse Reactions; Gastrointest | 1969 |
Iatrogenic gastrointestinal diseases in the aged.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Aged; Cathartics; Chemical and Drug Induced Li | 1972 |
Adverse reactions to non-steroidal antirheumatic drugs.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Aspirin; Benzophenones; Chemical and Drug Induced Liv | 1974 |
[Gastro-duodenal tolerance of some drugs with analgesic effect. Clinico-endoscopic considerations].
Topics: Analgesics; Anti-Inflammatory Agents; Antimalarials; Aspirin; Digestive System; Duodenal Ulcer; Esop | 1974 |
[Tolerance of long-term indomethacin treatment].
Topics: Adult; Aged; Arthritis, Rheumatoid; Central Nervous System Diseases; Chronic Disease; Drug Tolerance | 1972 |
Gout.
Topics: Allopurinol; Blood Cell Count; Cell Movement; Colchicine; Diet; Drug Synergism; Gastrointestinal Dis | 1974 |
Wy 23205, a new non-steroidal anti-inflammatory agent.
Topics: Animals; Anti-Inflammatory Agents; Arthritis; Aspirin; Bradykinin; Gastrointestinal Diseases; Guinea | 1971 |
An extended study of indomethacin. I. Clinical pharmacology.
Topics: Adult; Aged; Arthritis; Central Nervous System Diseases; Fibromyalgia; Gastrointestinal Diseases; He | 1966 |
[5 years of experience with indomethacin].
Topics: Adult; Aged; Arthritis; Arthritis, Rheumatoid; Chronic Disease; Eye; Female; Fibromyalgia; Gastroint | 1967 |
[Experiences with indomethacin in extra-articular rheumatism].
Topics: Gastrointestinal Diseases; Humans; Indomethacin; Neuralgia; Rheumatic Diseases; Spinal Diseases | 1971 |
[Current analgesic anti-inflammatory drugs].
Topics: Analgesics; Aniline Compounds; Anti-Inflammatory Agents; Aspirin; Chemical and Drug Induced Liver In | 1970 |
A nonsteroidal anti-inflammatory agent. Indomethacin (indocin).
Topics: Arthritis, Rheumatoid; Central Nervous System Diseases; Gastrointestinal Diseases; Humans; Indometha | 1966 |